Tulane researcher gets $2.6M in grants

NEW ORLEANS (AP) — Tulane University pathology professor Srikanta Dash has been awarded two National Institutes of Health grants totaling $2.6 million to study why some patients respond and other develop resistance to standard treatments for chronic hepatitis C.

The disease is the most common cause of end-stage liver disease.

Dash, director of Tulane’s hepatitis research laboratory, received a $1.4 million, four-year grant from the National Institute of Allergy and Infectious Diseases to explore the mechanisms behind a gene that plays a critical role in whether a patient with hepatitis C responds to antiviral treatment.

The second award is a $1.2 million National Cancer Institute grant to study how chronic hepatitis C develop resistance to interferon therapies.

KSN.com provides commenting to allow for constructive discussion on the stories we cover. In order to comment here, you acknowledge you have read and agreed to our Terms of Service. Commenters who violate these terms, including use of vulgar language or racial slurs, will be banned. Please be respectful of the opinions of others. If you see an inappropriate comment, please flag it for our moderators to review.

blog comments powered by Disqus